Alteplase is a recombinant tissue plasminogen activator (rtPA) used to treat acute ischemic stroke, myocardial infarction, and pulmonary embolism. Its primary function is to catalyze the conversion of plasminogen to plasmin, an enzyme responsible for the breakdown of blood clots.